Page 15 - FLIPBOOK
P. 15

• Efficacy (primary


                  endpoints)







                     • Decrease in voids/24

                         hour with mirabegron vs


                         placebo

                             • -0.7[0.2]; 95% CI -0.1,-0.3
   10   11   12   13   14   15   16   17   18   19   20